Department of Pharmacy, Michigan Medicine, Ann Arbor, MI, and University of Michigan College of Pharmacy, Ann Arbor, MI, USA.
Am J Health Syst Pharm. 2021 Apr 22;78(9):818-824. doi: 10.1093/ajhp/zxab051.
To describe the prevalence of burnout and secondary traumatic stress (STS) in health-system pharmacists during the coronavirus disease 2019 (COVID-19) pandemic.
A cross-sectional, professional pharmacy organization listserver-based online survey of a target group of health-system pharmacists across the United States was conducted. The survey was sent out through professional organization listservers and was anonymous and voluntary. The survey questionnaire included items regarding demographics and employment characteristics, COVID-19-related questions, a survey of respondents' perceptions of the prevalence and severity of burnout, and the Professional Quality of Life Scale (ProQOL). The ProQOL assessed respondents for compassion satisfaction (subcategorized as burnout and STS) and compassion fatigue. Descriptive statistics was used to assess the prevalence of burnout and STS.
Four hundred eighty-four health-system pharmacists completed the survey. Based on respondents' self-ratings of burnout, 47% were identified as having current burnout and 81% as having a history of burnout. Based on ProQOL scoring, 65.3% of respondents were identified as having a moderate or high likelihood of burnout, which was a prevalence higher than that indicated by respondents' self-ratings. Additionally, 51.4% of respondents were identified as having a moderate or high probability of STS and 99.4% as having a moderate or high probability of compassion satisfaction.
The survey found that over half of health-system pharmacists were affected with burnout, half with STS, and all with compassion satisfaction during the COVID-19 pandemic. Unfortunately, the development of burnout and STS in these health-system pharmacists may lead to several work-related consequences (eg, increase risk of medical errors, depression); therefore, addressing burnout and STS is crucial. Further studies of the consequences of burnout and STS during the COVID-19 pandemic are needed.
描述在 2019 年冠状病毒病（COVID-19）大流行期间，医疗系统药剂师中 burnout 和继发性创伤压力（STS）的流行情况。
对美国各地医疗系统药剂师进行了一项横断面、基于专业药学组织名录服务器的在线调查。通过专业组织名录服务器发送调查，匿名自愿参与。调查问卷包括人口统计学和就业特征、COVID-19 相关问题、调查受访者对 burnout 和 STS 的流行程度和严重程度的看法，以及职业生活质量量表（ProQOL）。ProQOL 评估受访者的同情心满足感（分为 burnout 和 STS）和同情心疲劳感。使用描述性统计数据评估 burnout 和 STS 的流行程度。
484 名医疗系统药剂师完成了调查。根据受访者自我评估的 burnout 程度，47%的人被确定为当前有 burnout，81%的人有 burnout 史。根据 ProQOL 评分，65.3%的受访者被认为有中度或高度 burnout 的可能性，这一比例高于受访者的自我评估。此外，51.4%的受访者被认为有中度或高度 STS 的可能性，99.4%的受访者有中度或高度同情心满足感的可能性。
该调查发现，在 COVID-19 大流行期间，超过一半的医疗系统药剂师受到 burnout 的影响，一半受到 STS 的影响，所有人都受到同情心满足感的影响。不幸的是，这些医疗系统药剂师中 burnout 和 STS 的发展可能会导致一些与工作相关的后果（例如，增加医疗失误的风险、抑郁）；因此，解决 burnout 和 STS 至关重要。需要进一步研究 COVID-19 大流行期间 burnout 和 STS 的后果。
